Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gansu Conbest Biotech is a specialized biotechnology company based in China that focuses on the research, development, and industrial-scale production of natural plant extracts and pharmaceutical intermediates. The company is a prominent supplier of high-purity active ingredients such as L-Dopa, Alpha-GPC, Huperzine A, and Phosphatidylserine, which are primarily used in the pharmaceutical and nutraceutical industries. Leveraging the rich botanical resources of the Gansu region, the firm operates advanced extraction and purification facilities to meet international quality standards. Their business model centers on providing standardized raw materials and custom manufacturing services for global health and wellness brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gansu Conbest Biotech.